Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK NEVEUX-ROELANS from Sint-Niklaas, company number BE0437102982, closed financial year 2025 with a result of € 88,183 after tax. For that financial year APOTHEEK NEVEUX-ROELANS recorded a gross margin of € 172,241 and equity of € 138,119. Compared with financial year 2024, the result moved from € 76,212 to € 88,183. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 138,119
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 88,183
▲ 16% vs 2024
Profit after tax over the fiscal year.
€ 99,431
▲ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 88,183 paid out
100 % of the profit went to the shareholders, mostly to NEVEUX (100 % of the shares). That is where the money ends up.
People and assets in 2025
0.4
Average over the fiscal year, from the social balance sheet.
€ 23,200
▲ 21% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 80,545
▼ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 297,977
▲ 20% vs 2024
€ 25,114 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 62,465
▼ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,657
▲ 63% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 87,585 | € 158,859 | € 155,503 | € 172,241 | ▲ 11% |
| Profit after taxes | € 22,827 | € 86,036 | € 76,212 | € 88,183 | ▲ 16% |
| Equity | € 60,083 | € 138,119 | € 138,119 | € 138,119 | |
| Total debts | € 587,832 | € 525,739 | € 493,672 | € 564,810 | ▲ 14% |
| Cash | € 83,633 | € 108,700 | € 77,441 | € 99,431 | ▲ 28% |
| Land & buildings | € 179,911 | € 168,383 | € 155,729 | € 227,030 | ▲ 46% |
| Retained profit | € 41,491 | € 119,527 | € 119,527 | € 119,527 | |
| Dividend | € 0 | € 8,000 | € 76,212 | € 88,183 | ▲ 16% |
| Bank debt | € 284,999 | € 266,755 | € 248,243 | € 297,977 | ▲ 20% |
| Balance sheet total | € 647,915 | € 663,858 | € 631,791 | € 702,929 | ▲ 11% |
| Employees (FTE) | 0.2 | 0.4 | 0.4 | 0.4 |
Key figures of APOTHEEK NEVEUX-ROELANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK NEVEUX-ROELANS?
What happened at APOTHEEK NEVEUX-ROELANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 88,183 (▲ 16% vs 2024). filed late Source: NBB ↗
- Neveux BV became a director. NBB
- New establishment in Sint-Niklaas. KBO
- Start of the company according to the CBE. KBO
In short
From € 22,827 profit in 2022 to € 88,183 profit in 2025.
Paid € 21,733 in corporate taxes since 2022.
Best year ever: 2025, with € 88,183 profit.
Paid out € 172,394 in dividends to the owners in total.
A new publication or filing at APOTHEEK NEVEUX-ROELANS? We notify you, reason included.
Follow APOTHEEK NEVEUX-ROELANSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NEVEUX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK NEVEUX-ROELANSBehind APOTHEEK NEVEUX-ROELANS is Neveux BV. The shares are held by NEVEUX (99.9%).
Establishments
Establishment units
Physical locations of this company
Moerlandstraat 104
9100 Sint-Niklaas
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
DSTNY-BACKBONE International Backbone, BE
Website info
Features
Security
Details
- Company number
- 0437.102.982
- VAT number
- BE 0437.102.982
- Registered office
- Moerlandstraat 104, 9100 Sint-Niklaas
- Names & denominations
- APOTHEEK NEVEUX-ROELANS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 March 1989
- Peppol
- Active · Active since 4 Jul 2025
- Contact
- aponr.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers